These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24296776)

  • 1. Antithrombin III supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life.
    Byrnes JW; Swearingen CJ; Prodhan P; Fiser R; Dyamenahalli U
    ASAIO J; 2014; 60(1):57-62. PubMed ID: 24296776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Recombinant Antithrombin III in Pediatric and Neonatal ECMO Patients.
    Todd Tzanetos DR; Myers J; Wells T; Stewart D; Fanning JJ; Sullivan JE
    ASAIO J; 2017; 63(1):93-98. PubMed ID: 27861430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin replacement during extracorporeal membrane oxygenation.
    Niebler RA; Christensen M; Berens R; Wellner H; Mikhailov T; Tweddell JS
    Artif Organs; 2011 Nov; 35(11):1024-8. PubMed ID: 22097980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.
    O'Meara LC; Alten JA; Goldberg KG; Timpa JG; Phillips J; Laney D; Borasino S
    ASAIO J; 2015; 61(3):339-44. PubMed ID: 25710768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin supplementation in adult patients receiving extracorporeal membrane oxygenation.
    Morrisette MJ; Zomp-Wiebe A; Bidwell KL; Dunn SP; Gelvin MG; Money DT; Palkimas S
    Perfusion; 2020 Jan; 35(1):66-72. PubMed ID: 31213179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Antithrombin III Products in Pediatric Patients Receiving Extracorporeal Membrane Oxygenation.
    Omecene NE; Kishk OA; Lardieri AB; Walker LK; Bhutta AT
    ASAIO J; 2020; 66(9):1042-1047. PubMed ID: 31977357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous supplementation of antithrombin III in adult and pediatric patients receiving extracorporeal membrane oxygenation.
    Sorial MN; Greene RA; Zullo AR; Berard-Collins C; Willis S
    Int J Artif Organs; 2020 May; 43(5):315-322. PubMed ID: 31750755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation.
    Nankervis CA; Preston TJ; Dysart KC; Wilkinson WD; Chicoine LG; Welty SE; Nelin LD
    ASAIO J; 2007; 53(1):111-4. PubMed ID: 17237658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study.
    Irby K; Swearingen C; Byrnes J; Bryant J; Prodhan P; Fiser R
    Pediatr Crit Care Med; 2014 May; 15(4):e175-82. PubMed ID: 24622165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin concentrates use in children on extracorporeal membrane oxygenation: a retrospective cohort study.
    Wong TE; Delaney M; Gernsheimer T; Matthews DC; Brogan TV; Mazor R; McMullan DM; Reiner AP; Konkle BA
    Pediatr Crit Care Med; 2015 Mar; 16(3):264-9. PubMed ID: 25581634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Antithrombin III Use in Achieving Anticoagulant Goals in Pediatric Patients.
    Jones AJ; O'Mara KL; Kelly BJ; Samraj RS
    J Pediatr Pharmacol Ther; 2017; 22(5):320-325. PubMed ID: 29042831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery.
    Kanbak M; Oc B; Salman MA; Ocal T; Oc M
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):593-9. PubMed ID: 21799398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III administration in neonates with congenital diaphragmatic hernia during the first three days of extracorporeal membrane oxygenation.
    Perry R; Stein J; Young G; Ramanathan R; Seri I; Klee L; Friedlich P
    J Pediatr Surg; 2013 Sep; 48(9):1837-42. PubMed ID: 24074654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin concentrate in pediatric patients requiring unfractionated heparin anticoagulation: a retrospective cohort study.
    Ryerson LM; Bauman ME; Kuhle S; Bruce AA; Massicotte MP
    Pediatr Crit Care Med; 2014 Oct; 15(8):e340-6. PubMed ID: 24901804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin Levels and Heparin Responsiveness during Venoarterial Extracorporeal Membrane Oxygenation: A Prospective Single-center Cohort Study.
    Mansour A; Berahou M; Odot J; Pontis A; Parasido A; Reizine F; Launey Y; Garlantézec R; Flecher E; Lecompte T; Nesseler N; Gouin-Thibault I
    Anesthesiology; 2024 Jun; 140(6):1153-1164. PubMed ID: 38271619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
    Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
    J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation.
    Panigada M; Cucino A; Spinelli E; Occhipinti G; Panarello G; Novembrino C; Consonni D; Protti A; Lissoni A; Arcadipane A; Pesenti A; Grasselli G
    Crit Care Med; 2020 Nov; 48(11):1636-1644. PubMed ID: 32947474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a novel anticoagulation strategy during ECMO in a pediatric population: single-center experience.
    Agati S; Ciccarello G; Salvo D; Turla G; Undar A; Mignosa C
    ASAIO J; 2006; 52(5):513-6. PubMed ID: 16966848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience with recombinant antithrombin to treat antithrombin deficiency in patients on extracorporeal membrane oxygenation.
    Niimi KS; Fanning JJ
    J Extra Corpor Technol; 2014 Mar; 46(1):84-90. PubMed ID: 24779124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Heparin-Antithrombin Product: A Novel Value for Pediatric Extracorporeal Anticoagulation.
    Rogerson CM; Hobson MJ
    J Extra Corpor Technol; 2022 Jun; 54(2):115-122. PubMed ID: 35928336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.